National Institute of General Medical Sciences; Notice of Closed Meetings, 66858 [2023-21154]

Download as PDF 66858 Federal Register / Vol. 88, No. 187 / Thursday, September 28, 2023 / Notices TABLE 2—ESTIMATED ANNUAL REPORTING BURDEN—BIOLOGICAL PRODUCTS 1 Number of recordkeepers 21 CFR section; activity Number of records per recordkeeper Total annual records Average burden per recordkeeper (in hours) Total hours 600.12; 2 Maintenance of Records .................................................................... 600.12(b)(2); Recall Records ............................................................................ 600.80(c)(1) and 600.80(k); AER Records ....................................................... 131 216 109 40.145 3.4028 7,503.95 5,259 735 817,931 32 24 1 168,288 17,640 817,931 Total ........................................................................................................... .......................... .......................... ........................ ........................ 1,003,859 1 There are no capital costs or operating and maintenance costs associated with this collection of information. 2 The recordkeeping requirements in § 610.18(b) are included in the estimate for § 600.12. TABLE 3—ESTIMATED ANNUAL REPORTING BURDEN—COMBINATION PRODUCTS 1 Number of respondents 21 CFR section; activity 4.102, 4.103, 4.104, 4.105; Postmarketing Safety Reporting for Combination Products, including associated reports and sharing information with other constituent part applicants. 1 There 11 Average burden per disclosure (in hours) Total annual disclosures 18 198 Total hours 0.35 (21 minutes) ... 69 are no capital costs or operating and maintenance costs associated with this collection of information. The burden for this information collection has changed since the last OMB approval. The reporting and recordkeeping burden has increased mostly due to an increase in the number of AER reports submitted to FDA and the associated recordkeeping with these reports. We have also added burden we believe attributable to post marketing safety reporting and attendant recordkeeping and disclosures, as required under part 4, subpart B. Dated: September 23, 2023. Lauren K. Roth, Associate Commissioner for Policy. [FR Doc. 2023–21252 Filed 9–27–23; 8:45 am] BILLING CODE 4164–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute of General Medical Sciences; Notice of Closed Meetings ddrumheller on DSK120RN23PROD with NOTICES1 Number of disclosures per respondents Pursuant to section 1009 of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. VerDate Sep<11>2014 18:09 Sep 27, 2023 Jkt 259001 Name of Committee: National Institute of General Medical Sciences Special Emphasis Panel; Renewal of Centers of Biomedical Research Excellence (COBRE) (Phase 2). Date: November 7–8, 2023. Time: 9:30 a.m. to 1:30 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, National Institute of General Medical Sciences, Natcher Building, 45 Center Drive, Bethesda, Maryland 20892 (Virtual Meeting). Contact Person: Nina Sidorova, Ph.D., Scientific Review Officer, Scientific Review Branch, National Institute of General Medical Sciences, National Institutes of Health, 45 Center Drive, MSC 6200, Room 3AN18–01, Bethesda, Maryland 20892, 301–594–3663, sidorova@nigms.nih.gov. Name of Committee: National Institute of General Medical Sciences Special Emphasis Panel; Review of MOSAIC K99/R00 applications. Date: November 9, 2023. Time: 10:00 a.m. to 5:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, National Institute of General Medical Sciences, Natcher Building, 45 Center Drive, Bethesda, Maryland 20892 (Virtual Meeting). Contact Person: Rebecca H. Johnson, Ph.D., Scientific Review Officer, Office of Scientific Review, National Institute of General Medical Sciences, National Institutes of Health, 45 Center Drive, MSC 6200, Room 3AN12B, Bethesda, Maryland 20892, 301–594–2771, johnsonrh@nigms.nih.gov. Name of Committee: National Institute of General Medical Sciences Special Emphasis Panel; Review of Support for Research Excellence (SuRE) Program (R16). Date: November 17, 2023. Time: 10:00 a.m. to 5:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, National Institute of General Medical Sciences, Natcher Building, 45 Center Drive, Bethesda, Maryland 20892 (Virtual Meeting). PO 00000 Frm 00063 Fmt 4703 Sfmt 4703 Contact Person: Rebecca H. Johnson, Ph.D., Scientific Review Officer, Office of Scientific Review, National Institute of General Medical Sciences, National Institutes of Health, 45 Center Drive, MSC 6200, Room 3AN12B, Bethesda, Maryland 20892, 301–594–2771, johnsonrh@nigms.nih.gov. (Catalogue of Federal Domestic Assistance Program No. 93.859, Biomedical Research and Research Training, National Institutes of Health, HHS) Dated: September 22, 2023. Miguelina Perez, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2023–21154 Filed 9–27–23; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Heart, Lung, and Blood Institute; Notice of Closed Meeting Pursuant to section 1009 of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: Heart, Lung, and Blood Initial Review Group; NHLBI E:\FR\FM\28SEN1.SGM 28SEN1

Agencies

[Federal Register Volume 88, Number 187 (Thursday, September 28, 2023)]
[Notices]
[Page 66858]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-21154]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute of General Medical Sciences; Notice of Closed 
Meetings

    Pursuant to section 1009 of the Federal Advisory Committee Act, as 
amended, notice is hereby given of the following meetings.
    The meetings will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Institute of General Medical 
Sciences Special Emphasis Panel; Renewal of Centers of Biomedical 
Research Excellence (COBRE) (Phase 2).
    Date: November 7-8, 2023.
    Time: 9:30 a.m. to 1:30 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, National Institute of 
General Medical Sciences, Natcher Building, 45 Center Drive, 
Bethesda, Maryland 20892 (Virtual Meeting).
    Contact Person: Nina Sidorova, Ph.D., Scientific Review Officer, 
Scientific Review Branch, National Institute of General Medical 
Sciences, National Institutes of Health, 45 Center Drive, MSC 6200, 
Room 3AN18-01, Bethesda, Maryland 20892, 301-594-3663, 
[email protected].

    Name of Committee: National Institute of General Medical 
Sciences Special Emphasis Panel; Review of MOSAIC K99/R00 
applications.
    Date: November 9, 2023.
    Time: 10:00 a.m. to 5:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, National Institute of 
General Medical Sciences, Natcher Building, 45 Center Drive, 
Bethesda, Maryland 20892 (Virtual Meeting).
    Contact Person: Rebecca H. Johnson, Ph.D., Scientific Review 
Officer, Office of Scientific Review, National Institute of General 
Medical Sciences, National Institutes of Health, 45 Center Drive, 
MSC 6200, Room 3AN12B, Bethesda, Maryland 20892, 301-594-2771, 
[email protected].

    Name of Committee: National Institute of General Medical 
Sciences Special Emphasis Panel; Review of Support for Research 
Excellence (SuRE) Program (R16).
    Date: November 17, 2023.
    Time: 10:00 a.m. to 5:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, National Institute of 
General Medical Sciences, Natcher Building, 45 Center Drive, 
Bethesda, Maryland 20892 (Virtual Meeting).
    Contact Person: Rebecca H. Johnson, Ph.D., Scientific Review 
Officer, Office of Scientific Review, National Institute of General 
Medical Sciences, National Institutes of Health, 45 Center Drive, 
MSC 6200, Room 3AN12B, Bethesda, Maryland 20892, 301-594-2771, 
[email protected].

(Catalogue of Federal Domestic Assistance Program No. 93.859, 
Biomedical Research and Research Training, National Institutes of 
Health, HHS)

     Dated: September 22, 2023.
Miguelina Perez,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2023-21154 Filed 9-27-23; 8:45 am]
BILLING CODE 4140-01-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.